ADAP
Asset Logo

Adaptimmune Therapeutics plc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-3.94%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types. Its cell therapy candidates include TCR T-cells and TruC T-cells. Its product candidates include afamitresgene autoleucel (afami-cel) and Lete-cel. The afamicel is a cell therapy that provides a treatment option for people with synovial sarcoma. The Company is in the process of transitioning lete-cel, which targets the NY-ESO antigen in people with synovial sarcoma and myxoid round cell liposarcoma (MRCLS). Its clinical pipeline includes SURPASS-III Phase II Trial with ADP-A2M4CD8 and SURPASS Phase I Trial with ADP-A2M4CD8. The Company’s most advanced pre-clinical programs are for T-cell therapies directed to the PRAME target (ADP-600) and to CD70 (ADP-520). ADAP-600 is an engineered TCR T-cell.

📈 Performance

Price History*

-95.86%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.67

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ADAP

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

1 days

💵 Average investment amount

$63

Last time a customer invested in ADAP

78 days
ADAP investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in ADAP also invest in...

Gilead Sciences Inc.

GILD

🙌 Performance (5Yr p.a)

6.97%

📊 Share price

$88.63 USD
Find Out More

🙌 Performance (5Yr p.a)

16.04%

📊 Share price

$45.28 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-12.22%

📊 Share price

$30.68 USD

🙌 Performance (5Yr p.a)

33.29%

📊 Share price

$70.98 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

8.75%

📊 Share price

$24.42 USD

📈 HIGH PRICE GROWTH

Want more shares? Try these...

🙌 Performance (5Yr p.a)

13.42%

📊 Share price

$499.50 USD

📈 HIGH PRICE GROWTH

📊 Share price

$2.09 USD
Compare
Add to watchlist